The application of pharmacogenetics in identifying single nucleotide polymorphisms (SNPs) in DNA sequences that cause clinically significant alterations in drug-metabolizing enzyme activities is ...

Current evidence shows that genetic variation can determine impaired response to drugs. Polymorphisms can exert an effect on drug action anywhere in the body. Individually, an SNP that alters ...